Colm Burke (Fine Gael) | Oireachtas source

Unannounced scrutiny has been set up, but where does that leave us in terms of imported products? I refer to products coming in from outside the European Union, for which we will not have the same powers of inspection. How will we control that area? If there is a lower level of scrutiny in non-European jurisdictions, does that cause problems from an industrial point of view for medical device companies in this country? How is the issue being addressed?